Emily Marchiano, MD

Most people are quite anxious when they’re coming to meet me, so I try to be a calming presence and give them the information they need in a way that responds to where they are emotionally. Many of the cancers I treat are relatively rare, and there are only a few clusters in the U.S. where patients can access all of the experts in the field. I am very proud to be a part of one of them and be able to bring this treatment to those who need it.

Emily J. Marchiano, MD, joined the University of Washington faculty in 2022. She is currently an assistant professor in the Department of Otolaryngology – Head and Neck Surgery.  Dr. Marchiano graduated with an MD degree from Rutgers New Jersey Medical School in Newark, NJ. She then went on to complete her residency training in otolaryngology – head and neck surgery at the University of Michigan in Ann Arbor, MI. She then completed a year of training in head and neck oncology and microvascular surgery with Dr. Futran at the University of Washington where she has remained as faculty.

Board-certified in otolaryngology, Dr. Marchiano offers expertise in both head and neck oncology and microvascular reconstruction. Her comprehensive practice encompasses the treatment of mucosal head and neck cancers, benign and malignant endocrine tumors, and cutaneous malignancies. Additionally, she specializes in managing benign and malignant salivary gland disorders.

Dr. Marchiano is passionate about medical and resident education. She serves as the medical student clerkship direct and helps to mentor medical students interested in a future career in otolaryngology. She is actively pursuing research in both salivary gland malignancies and oral cavity cancer. She is currently enrolling patients in a clinical trial to optimize intraoperative margin status in oral cavity cancer utilizing fluorescent dye. 

Medical School: Rutgers New Jersey Medical School, 2016

Residency: University of Michigan in Ann Arbor Residency in Head and Neck Surgery, 2021

Fellowship: University of Washington Head and Neck Oncology and Microvascular Surgery Fellowship, 2021

Board Certification: Otolaryngology-Head and Neck Surgery, 2022

Memberships: American Head and Neck Society, American Academy of Otolaryngology-Head & Neck Surgery

Dr. Marchiano’s clinical interests include surgery for head and neck cancers, salivary gland cancer, and skin cancers affecting the head and neck including melanoma and Merkel Cell Carcinoma. Dr. Marchiano also specializes in thyroid, endocrine, and neuroendocrine tumors. Dr. Marchiano launched a multi-disciplinary clinic with Endocrinologists at Fred Hutch Cancer Center in November 2023.

Endocrine Tumors
Head and Neck Cancers
Melanoma
Merkel Cell Carcinoma
Neuroendocrine Tumors
Salivary Gland Cancer

Dermody SM, McMichael BM, Bellile E, Marchiano EJ, Chinn SB. Lymph node level ratio as a predictor of survival in oral cavity squamous cell carcinoma. Oral Oncol. 2023 Nov;146:106572. doi: 10.1016/j.oraloncology.2023.106572. Epub 2023 Sep 23. PMID: 37742470.

Pan C, Wu QV, Voutsinas J, Houlton JJ, Barber B, Rizvi ZH, Marchiano E, Futran N, Laramore GE, Liao JJ, Parvathaneni U, Martins RG, Fromm JR, Rodriguez CP. Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors. Cancer Med. 2023 Apr;12(8):9384-9391. doi: 10.1002/cam4.5697. Epub 2023 Feb 21. PMID: 36806947; PMCID: PMC10166901.

Marchiano E, Kana L, Bellile E, Smith JD, Casper KA, Malloy KM, Chinn SB, Stucken CL, Prince MEP, Chepeha DB, Rosko AJ, Spector ME. Neurotization of the radial forearm free flap improves swallowing outcomes in hemiglossectomy defects. Head Neck. 2023 Apr;45(4):798-805. doi: 10.1002/hed.27290. Epub 2022 Dec 29. PMID: 36579434.

Chen JX, Miller LE, Filimonov A, Shuman EA, Marchiano E, George BC, Thorne M, Pletcher SD, Platt M, Teng M, Kozin ED, Gray ST. Factors affecting operative autonomy and performance during otolaryngology training: A multicenter trial. Laryngoscope Investig Otolaryngol. 2022 Feb 1;7(2):404-408. doi: 10.1002/lio2.750. PMID: 35434323; PMCID: PMC9008171.

Chen JX, Deng F, Filimonov A, Shuman EA, Marchiano E, George BC, Thorne M, Pletcher SD, Platt M, Teng MS, Kozin ED, Gray ST. Multi-institutional Study of Otolaryngology Resident Intraoperative Experiences for Key Indicator Procedures. Otolaryngol Head Neck Surg. 2022 Aug;167(2):268-273. doi: 10.1177/01945998211050350. Epub 2021 Oct 5. PMID: 34609936.

Dr. Marchiano is actively pursuing research in both salivary gland malignancies and oral cavity cancer. She is currently enrolling patients in a clinical trial to optimize intraoperative margin status in oral cavity cancer utilizing fluorescent dye. She is the investigator/study contact for Intraoperative Visualization of Oral Cavity Squamous Cell Carcinoma and High-Grade Dysplasia with Tozuleristide, a Fluorescent Tumor Marking Agent (Trial phase: I/II) sponsored by University of Washington/Fred Hutch.